Tradestie Institutional Equity Comparison Engine
KVAC vs PSTV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PSTV Overall Edge
PSTV Captures Institutional Edge (2โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PLUS THERAPEUTICS, Inc. Common Stock (PSTV) driven by superior Valuation, Momentum & Technical while KVAC counters with relative strength in Growth & Margin. Fundamentally, KVAC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PSTV at 1.0x Forward P/E and -692.5% operating margin (-2.9% YoY). In options structure, KVAC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PSTV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PSTV
KVAC N/M vs PSTV 1.0x Fwd P/E
Growth & Margin Winner
KVAC
Op Margin 0.0% vs -692.5% ยท YoY +0.0% vs -2.9%
Momentum & Technical Winner
PSTV
1Y -1.8% vs +741.3% ยท 52W Pos 0% vs 48%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KVAC
US Equity
Keen Vision Acquisition Corporation
Blank Checks
$11.51
-13.13% 1D
Market Cap
$73.0M
1M Return
-6.42%
1Y Return
-1.79%
Forward P/E
N/M
Unified AI Score
58.0 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
PSTV
NASDAQ
PLUS THERAPEUTICS, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$3.87
+6.03% 1D
Market Cap
$25.1M
1M Return
-6.97%
1Y Return
+741.3%
Forward P/E
1.0x
Unified AI Score
59.8 / 100
HOLD
Tech 45.0
Fund 53.0
Flow 50.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KVAC -1.79%
PSTV +741.3%
Spread: +591.88 pp (PSTV Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
KVAC TTM Op. Margin: 0.0%
PSTV TTM Op. Margin: -692.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KVAC vs PSTV. Trailing 12-month operating profitability (KVAC 0.0% vs PSTV -692.5%) and valuation multiples (KVAC N/M vs PSTV 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KVAC | PSTV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $73.0M | $25.1M | Larger Scale | KVAC |
| Trailing P/E Ratio Valuation | 88.3x | 0.2x | Lower Multiple | PSTV |
| Forward P/E Ratio Valuation | N/M | 1.0x | Lower Multiple | PSTV |
| Revenue Growth (YoY) Growth | +0.0% | -2.9% | Higher Growth | KVAC |
| Operating Margin (TTM) Profitability | 0.0% | -692.5% | Higher Margin | KVAC |
| Net Profit Margin Profitability | 0.0% | -230.2% | Higher Margin | KVAC |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -522.5% | Higher ROE | KVAC |
| 52-Week Range Position Momentum | 0% ($12โ$19) | 48% ($0โ$8) | Stronger Trend | PSTV |
| Beta / 30D Volatility Risk Regime | -0.17ฮฒ ยท 76% Vol | 2.04ฮฒ ยท 50% Vol | Lower Realized Risk | PSTV |
| Unified Institutional Score Composite Signal | 58.0 / 100 (HOLD) | 59.8 / 100 (HOLD) | Higher Composite | PSTV |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KVAC vs PSTV Buy Guide
KVAC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PSTV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KVAC nor PSTV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.